Equities researchers at StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX – Get Free Report) in a research note issued on Monday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock.
Athersys Price Performance
Shares of NASDAQ ATHX opened at $0.01 on Monday. The firm has a market cap of $833,206.50, a price-to-earnings ratio of -0.01 and a beta of -0.90. Athersys has a 1 year low of $0.01 and a 1 year high of $1.99.
About Athersys
Want More Great Investing Ideas?
Further Reading
- Five stocks we like better than Athersys
- Breakout Stocks: What They Are and How to Identify Them
- Is Spotify Stock Poised to Soar? Options Traders Think So
- The Most Important Warren Buffett Stock for Investors: His Own
- Misses and Beats: 3 Stocks That Are Moving Markets Right Now
- Earnings Per Share Calculator: How to Calculate EPS
- Cisco on the Rise: AI Potential and Analyst Upgrades Drive Gains
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.
